Position in QGEN
as of Mar 31, 2026
· filed Jun 3, 2026
Position Value
$760
-$848 QoQ
Shares Held
19
-47.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NewEdge Advisors, LLC holds $58,986,020 across 23 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
54,764 | $10,431,446 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
19,936 | $9,995,112 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
14,787 | $7,784,468 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
35,788 | $6,914,957 | |
| 5 | NTRA |
Natera, Inc.
|
23,730 | $6,441,508 | |
| 6 | A |
Agilent Technologies, Inc.
|
28,456 | $3,779,810 | |
| 7 | LH |
Labcorp Holdings Inc.
|
11,004 | $3,081,120 | |
| 8 | DGX |
Quest Diagnostics Inc
|
12,508 | $2,651,070 |
All Filings in QGEN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $760 | 19 | Shares | Sole | 2026-06-03 | |
| 2025-09-30 | $1,608 | 36 | Shares | Sole | 2025-11-17 | |
| 2024-09-30 | $1,002 | 22 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $903 | 22 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $3,869 | 90 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,930 | 110 | Shares | Sole | 2024-02-13 | |
| 2023-03-31 | $690,372 | 14,565 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $768,275 | 14,928 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $605,226 | 14,207 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||